These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19752003)

  • 1. Nasal septum perforation in a breast cancer patient treated with bevacizumab.
    Marín AP; Sánchez AR; Arranz EE
    Ann Oncol; 2009 Nov; 20(11):1901-2. PubMed ID: 19752003
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Traina TA; Norton L; Drucker K; Singh B
    Oncologist; 2006; 11(10):1070-1. PubMed ID: 17110625
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nasal septum perforation and bevacizumab].
    Bengrine-Lefevre L; Afchain P; Chibaudel B; Gervais H; Tournigand C; De Gramont A; Louvet C
    Rev Med Interne; 2011 Apr; 32(4):e43-5. PubMed ID: 21470582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab-induced nasal septum perforation.
    Fakih MG; Lombardo JC
    Oncologist; 2006 Jan; 11(1):85-6. PubMed ID: 16401718
    [No Abstract]   [Full Text] [Related]  

  • 5. A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer.
    Petrelli F; Cabiddu M; Barbara C; Barni S
    Breast Cancer; 2011 Jul; 18(3):226-30. PubMed ID: 21312011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.
    Mailliez A; Baldini C; Van JT; Servent V; Mallet Y; Bonneterre J
    Br J Cancer; 2010 Sep; 103(6):772-5. PubMed ID: 20736943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal septum perforation and bevacizumab.
    Power DG; Kemeny NE
    Med Oncol; 2011 Mar; 28(1):89-93. PubMed ID: 20213219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy.
    Burkart CM; Grisel JJ; Hom DB
    Laryngoscope; 2008 Sep; 118(9):1539-41. PubMed ID: 18622319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
    Rodriguez CA; Martin T; Lozano R; Gomez A; Cruz JJ
    Breast J; 2017 Nov; 23(6):745-746. PubMed ID: 28845572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab-associated osteonecrosis of the jaw.
    Greuter S; Schmid F; Ruhstaller T; Thuerlimann B
    Ann Oncol; 2008 Dec; 19(12):2091-2. PubMed ID: 18977851
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute lung injury associated with docetaxel and bevacizumab.
    Prat A; Martínez P; Serrano C; Montero MA; Andreu J; Cortés J
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):803-5. PubMed ID: 17889516
    [No Abstract]   [Full Text] [Related]  

  • 12. Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer.
    Ruiz N; Fernandez-Martos C; Romero I; Pla A; Maiquez J; Calatrava A; Guillem V
    J Clin Oncol; 2007 Aug; 25(22):3376-7. PubMed ID: 17664487
    [No Abstract]   [Full Text] [Related]  

  • 13. Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer.
    Farhat MH; El-Saghir NS; Shamseddine AI
    Breast; 2009 Feb; 18(1):66-8. PubMed ID: 19013064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel.
    Philippin-Lauridant G; Thureau S; Ouvrier MJ; Blot E
    Ann Oncol; 2008 Nov; 19(11):1977-8. PubMed ID: 18801882
    [No Abstract]   [Full Text] [Related]  

  • 15. Bevacizumab beyond progression in breast cancer.
    Dirix LY; Reynolds AR
    Lancet Oncol; 2014 Oct; 15(11):1190-1. PubMed ID: 25273341
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study.
    Sfakianos GP; Numnum TM; Halverson CB; Panjeti D; Kendrick JE; Straughn JM
    Gynecol Oncol; 2009 Sep; 114(3):424-6. PubMed ID: 19552944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
    Mallmann P
    Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difficulties in echocardiographic monitoring of trastuzumab therapy in breast cancer patients: case report and review of recommendations].
    Duchnowska R; Szmit S; Szczylik C; Opolski G
    Kardiol Pol; 2008 Aug; 66(8):895-8. PubMed ID: 18803144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].
    Mychaluk J; Piprot C; Sevestre H; Merviel P; Gondry J; Fauvet R
    Presse Med; 2009 Sep; 38(9):1370-4. PubMed ID: 19349140
    [No Abstract]   [Full Text] [Related]  

  • 20. Current perspective - trastuzumab.
    Hall PS; Cameron DA
    Eur J Cancer; 2009 Jan; 45(1):12-8. PubMed ID: 19042123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.